As part of the deal, DKSH will provide marketing, sales, warehousing, physical distribution, credit management and collection services for BMS in certain markets.
DKSH offers a tailor-made, integrated package of services for each market.
The agreements memorialize the renewal of the current regional relationship between the two firms and underline the growing need of healthcare companies to reduce the number of service providers they work with in each region to limit complexity and increase the possibilities for interaction on a Pan-Asian level.
DKSH Business Unit Healthcare director of Regional Business Development Pharmaceuticals Thomas Delemazure said,"We are delighted to extend our regional relationship with Bristol-Myers Squibb in six Asian markets and look forward to helping Bristol-Myers Squibb grow their business with our integrated commercial and distribution platform."
The agreement underlines DKSH’s position as partner of choice for healthcare companies wanting to focus on their core competencies while ensuring their growth in Asia.
The deal will further strengthen DKSH’s market position in Asia as well as contribute incrementally to the Group’s overall profitability over time.